251 related articles for article (PubMed ID: 27673409)
1. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
Ma Y; Lu Y; Lu B
Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
[TBL] [Abstract][Full Text] [Related]
2. UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis.
Yang Y; Jiang Y; Wan Y; Zhang L; Qiu J; Zhou S; Cheng W
Tumour Biol; 2016 Aug; 37(8):10633-41. PubMed ID: 26867765
[TBL] [Abstract][Full Text] [Related]
3. The Role of Long Non-Coding RNAs in Ovarian Cancer.
Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
[TBL] [Abstract][Full Text] [Related]
4. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
[TBL] [Abstract][Full Text] [Related]
5. A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
Langhe R; Norris L; Saadeh FA; Blackshields G; Varley R; Harrison A; Gleeson N; Spillane C; Martin C; O'Donnell DM; D'Arcy T; O'Leary J; O'Toole S
Cancer Lett; 2015 Jan; 356(2 Pt B):628-36. PubMed ID: 25451316
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review).
Palma Flores C; García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Astudillo de la Vega H; Marchat LA; Salinas Vera YM; López-Camarillo C
Int J Oncol; 2017 May; 50(5):1461-1476. PubMed ID: 28393213
[TBL] [Abstract][Full Text] [Related]
7. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
Panoutsopoulou K; Avgeris M; Scorilas A
Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA in glioma: signaling pathways.
Shi J; Dong B; Cao J; Mao Y; Guan W; Peng Y; Wang S
Oncotarget; 2017 Apr; 8(16):27582-27592. PubMed ID: 28187439
[TBL] [Abstract][Full Text] [Related]
9. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
10. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
11. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma.
Jia LF; Wei SB; Gan YH; Guo Y; Gong K; Mitchelson K; Cheng J; Yu GY
Int J Cancer; 2014 Nov; 135(10):2282-93. PubMed ID: 24343426
[TBL] [Abstract][Full Text] [Related]
12. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Perakis SO; Thomas JE; Pichler M
Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in Ovarian Cancer.
Katz B; Tropé CG; Reich R; Davidson B
Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
[TBL] [Abstract][Full Text] [Related]
14. Herpes virus microRNA expression and significance in serous ovarian cancer.
Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer.
Li J; Yu H; Xi M; Lu X
J Ovarian Res; 2016 Aug; 9(1):49. PubMed ID: 27535740
[TBL] [Abstract][Full Text] [Related]
16. Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer.
De Leeneer K; Claes K
Adv Exp Med Biol; 2015; 867():263-75. PubMed ID: 26530371
[TBL] [Abstract][Full Text] [Related]
17. The cross talk between long, non-coding RNAs and microRNAs in gastric cancer.
Deng K; Wang H; Guo X; Xia J
Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):111-6. PubMed ID: 26621794
[TBL] [Abstract][Full Text] [Related]
18. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
19. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
20. microRNA and Ovarian Cancer.
Langhe R
Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
